|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-8-5
|
|
pubmed:abstractText |
The paper describes a procedure for manufacturing the new anthelminthic Tizanox. It shows it necessary to administer a larger dose of the drug than that of azinox (praziquantel) to treat experimental hymenolepiasis. However, the lower toxicity of Tizanox enhances its chemotherapeutical index.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0025-8326
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-51
|
|
pubmed:dateRevised |
2009-10-21
|
|
pubmed:meshHeading |
pubmed-meshheading:10414049-Animals,
pubmed-meshheading:10414049-Anticestodal Agents,
pubmed-meshheading:10414049-Dose-Response Relationship, Drug,
pubmed-meshheading:10414049-Drug Evaluation, Preclinical,
pubmed-meshheading:10414049-Hymenolepiasis,
pubmed-meshheading:10414049-Isoquinolines,
pubmed-meshheading:10414049-Mice,
pubmed-meshheading:10414049-Praziquantel,
pubmed-meshheading:10414049-Spectrophotometry, Infrared,
pubmed-meshheading:10414049-Thiadiazines
|
|
pubmed:articleTitle |
[The technology for manufacturing antiparasitic preparations. 9. The new preparation tizanox and an evaluation of its anti-Hymenolepis activity].
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
